AI-Designed IPF Drug Rentosertib Shows Biological Age Reversal in Trial

A study published in Nature Biotechnology by Insilico Medicine shows that Rentosertib, an anti-fibrotic candidate whose target selection and molecular design were guided by generative AI, reduced predicted biological age in a 42-patient randomized placebo-controlled Phase 2a trial in idiopathic pulmonary fibrosis. After 12 weeks, all six aging clocks developed by independent teams moved toward younger predicted age, averaging roughly 3-4 years, with some accounts citing up to 6 years. It is hailed as the first human anti-aging signal from an AI-designed drug; data debuted at the Nature AI Healthcare conference in Paris and was covered by the New York Times' Cade Metz.

Confirmed

• Rentosertib targets idiopathic pulmonary fibrosis, designed with a dual AI system, described as the first AI-generated drug in development, now in Phase 3
• In the 42-patient trial, all six proteomic aging clocks shifted younger in the treatment group while the placebo group changed little or rose slightly, per @DrSingularity
• The drug altered 326 circulating proteins, implicating senescence, metabolism and other aging-related pathways; lung function improvement was also reported

Unconfirmed

• Eric Topol notes the finding would be striking only if validated in larger, independent studies; sample size and long-term safety remain unverified, and the link between clock reversal and actual aging delay is unproven. Some posts state a 4-week rather than 12-week treatment duration, so exact figures should follow the formal paper

Why it matters

• It is the first human anti-aging signal from an AI-designed drug, potentially expanding AI drug discovery beyond original indications; @MaxUnfried called it a historic moment for aging research
• Researcher @DrBischof says organ-specific clocks and dose stratification will inform future trial design

2026-09-07 ~ 2026-09-09 · 18 related posts

• [source] AI-designed drug rentosertib slowed 6 of 6 proteomic aging clocks in trial — EricTopol · 2026-09-07
• Eric Topol hails AI trial methods covered by NYT: "exciting if confirmed" — EricTopol · 2026-09-07
• Early data suggests an AI-developed drug could slow aging — Dr_Singularity · 2026-09-07
• [source] AI-developed drug rentosertib shows early anti-aging signals across six aging clocks — Dr_Singularity · 2026-09-07
• AI-designed drug Rentosertib unexpectedly lowered patients' biological age markers by 6 years — Distinct-Question-16 · 2026-09-08
• AI-designed drug rentosertib cut patients' biological age by up to 6 years in 4-week Phase 2 study — Polymarket · 2026-09-08
• [source] AI-designed drug rentosertib shows 3-4 year biological age reversal across six aging clocks — alex_verem · 2026-09-09
• AI-discovered lung drug Rentosertib appears to slow biological aging by 3-4 years — coinfanking · 2026-09-09

10 near-duplicate retellings: coherence · AllThingsApx · Dr_Singularity · NinaDSchick · ceciletamura · MaxUnfried · HealthcareAIGuy · coherence · rand_longevity · xiaohu